Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
5 Top Momentum Stocks To Buy As Market Bounces Back By Zacks Investment Research - Feb 14, 2018

Wall Street showed a strong revival from the vicious sell-off seen last week, with major indices back in the green territory for the year. Both the Dow Jones Industrial Average and the S&P 500...

Zacks Investment Research
SodaStream (SODA) Shares Rally On Q4 Earnings, Revenues Beat By Zacks Investment Research - Feb 14, 2018

SodaStream International Ltd. (NASDAQ:SODA) came up with impressive results in the final quarter of 2017, beating the Zacks Consensus Estimate on both counts. The company’s shares gained 4.9%...

Zacks Investment Research
EQT Corp (EQT) Beats Earnings And Revenues Estimates In Q4 By Zacks Investment Research - Feb 14, 2018

EQT Corporation (NYSE:EQT) posted fourth-quarter 2017 adjusted earnings per share of 76 cents, beating the Zacks Consensus Estimate of 22 cents. The figure also increased 204% from 25 cents in the...

Zacks Investment Research
Reliance Steel's (RS) Q4 Earnings & Sales Beat Estimates By Zacks Investment Research - Feb 14, 2018

Reliance Steel & Aluminum Co. (NYSE:RS) is a leading metals service center company engaged in value-added materials management and metals processing services. Earnings Reliance Steel’s...

Zacks Investment Research
Inogen (INGN) Gains On Diverse Product Line, Competition Rife By Zacks Investment Research - Feb 14, 2018

On Feb 14, we issued an updated research report on leading medical devices company Inogen, Inc. (NASDAQ:INGN) .Based in California, Inogen develops, manufactures and markets portable oxygen cylinders...

Zacks Investment Research
J&J (JNJ) Gets FDA Nod For New Prostrate Cancer Treatment By Zacks Investment Research - Feb 14, 2018

Johnson & Johnson’s (NYSE:JNJ) subsidiary, Janssen Biotech announced that the FDA has approved its new drug application (NDA) for apalutamide for the treatment of men with non-metastatic...

Zacks Investment Research
Getting Over The Hump By Zacks Investment Research - Feb 14, 2018

Hey everybody, Dave Bartosiak filling in for Jim Giaquinto today. He’ll be back with you folks again tomorrow. Are you starting to feel better about the market right now? Technically...

Zacks Investment Research
Nickel ETF (JJN) Hits New 52-Week High By Zacks Investment Research - Feb 14, 2018

For investors seeking momentum, iPath Bloomberg Nickel Subindex Total Return ETN JJN is probably on radar now. The fund just hit a 52-week high, and is up 69.6% from its 52-week low price of...

Zacks Investment Research
Cincinnati Bell (CBB) Incurs Loss In Q4 By Zacks Investment Research - Feb 14, 2018

Cincinnati Bell Inc. (NYSE:CBB) is a leading regional diversified telecom and technology service provider to both residential and business customers. The company operates through three segments:...

Zacks Investment Research
Avon Products (AVP) Q4 Earnings Beat, Revenue Miss Estimates By Zacks Investment Research - Feb 14, 2018

Avon Products, Inc. (NYSE:AVP) , the leading manufacturer and marketer of beauty and related products, reported fourth-quarter 2017 results. The company posted adjusted earnings from continuing...

Zacks Investment Research
Applied Materials (AMAT) Beats On Q1 Earnings And Revenues By Zacks Investment Research - Feb 14, 2018

Applied Materials Inc. (NASDAQ:AMAT) reported robust first-quarter fiscal 2018 results, with both the top and the bottom lines surpassing the Zacks Consensus Estimate.The company’s pro forma...

Zacks Investment Research
Incyte (INCY) Beats On Sales In Q4 By Zacks Investment Research - Feb 14, 2018

Wilmington, DE-based Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.Incyte’s lead drug,...

Zacks Investment Research
Nektar (NKTR) Surges: Stock Moves 11% Higher By Zacks Investment Research - Feb 14, 2018

Nektar Therapeutics (NASDAQ:NKTR) was a big mover last session, as the company saw its shares rise more than 11% on the day. The move came on solid volume too with far more shares changing hands...

Zacks Investment Research
Retail Sales Fall: Which Way Is The Sector Headed? By Zacks Investment Research - Feb 14, 2018

U.S. retail sales registered the steepest decline in almost a year during January. The Commerce Department stated that U.S. retail and food services sales were down 0.3% to $492 billion. The fall was...

Continue with Apple
Continue with Google
or
Sign up with Email